Mihail Celeski: Personalizing Anticoagulant Therapy for Frail Patients With Atrial Fibrillation
Mihail Celeski, Clinical and Interventional Cardiologist at Fabrizio Spaziani Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The American Journal of Cardiology adding:
”New Publication: Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population -Proud to be part of the team behind this work, guided by Lorenzo Scalia .
In this paper, we summarize the current evidence on anticoagulant therapy for elderly and frail patients with non-valvular atrial fibrillation, highlighting the benefits of DOACs, the importance of individualized treatment, and emerging strategies to optimize stroke prevention while reducing bleeding risk.”
Title: Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population
Authors: Lorenzo Scalia, Laura Gatto, Federica Agnello, Dario Calderone, Mihail Celeski, Antonio Popolo Rubbio, Francesco Prati, Luca Testa, Davide Capodanno, Marco Barbanti
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters